Edition:
India

Akcea And Ionis Announce Approval Of Waylivra In The European Union


Tuesday, 7 May 2019 

May 7 (Reuters) - Akcea Therapeutics Inc ::AKCEA AND IONIS ANNOUNCE APPROVAL OF WAYLIVRA® (VOLANESORSEN) IN THE EUROPEAN UNION.AKCEA THERAPEUTICS - APPROVAL OF WAYLIVRA IN EU AS ADJUNCT TO DIET IN ADULT PATIENTS WITH GENETICALLY CONFIRMED FCS AND AT HIGH RISK FOR PANCREATITIS.